Younossi ZM, Golabi P, Price JK, Owrangi S, Gundu-Rao N, Satchi R, et al. The global epidemiology of Nonalcoholic fatty liver disease and Nonalcoholic steatohepatitis among patients with Type 2 diabetes. Clin Gastroenterol Hepatol. 2024;22(10):1999-2010 e8. https://doi.org/10.1016/j.cgh.2024.03.006
Hodson L, Gunn PJ. The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state. Nat Rev Endocrinol. 2019;15(12):689–700. https://doi.org/10.1038/s41574-019-0256-9. (PubMed PMID: 31554932)
Article CAS PubMed Google Scholar
Myers MG Jr., Affinati AH, Richardson N, Schwartz MW. Central nervous system regulation of organismal energy and glucose homeostasis. Nat Metab. 2021;3(6):737–750. https://doi.org/10.1038/s42255-021-00408-5. (Epub 20210621. PubMed PMID: 34158655.)
Article CAS PubMed Google Scholar
Yang S, Yang H, Chang R, Yin P, Yang Y, Yang W, et al. MANF regulates hypothalamic control of food intake and body weight. Nat Commun. 2017;8(1): 579. https://doi.org/10.1038/s41467-017-00750-x
Article CAS PubMed PubMed Central Google Scholar
He Y, Zhang C, Wu S, Li K, Zhang S, Tian M, et al. Central NUCB2/nesfatin-1 signaling ameliorates liver steatosis through suppression of endoplasmic reticulum stress in the hypothalamus. Metabolism. 2025;162: 156046. https://doi.org/10.1016/j.metabol.2024.156046
Article CAS PubMed Google Scholar
Rose JP, Morgan DA, Sullivan AI, Fu X, Inigo-Vollmer M, Burgess SC, et al. FGF21 reverses MASH through coordinated actions on the CNS and liver. Cell Metab. 2025;37(7):1515–29 e6. https://doi.org/10.1016/j.cmet.2025.04.014
Article CAS PubMed PubMed Central Google Scholar
Dichtel LE, Cordoba-Chacon J, Kineman RD. Growth hormone and insulin-like growth factor 1 regulation of Nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2022;107(7):1812–1824. https://doi.org/10.1210/clinem/dgac088.PubMedPMID:35172328;PubMedCentralPMCID:PMC9202731
Article PubMed PubMed Central Google Scholar
Fan H, Liu Z, Zhang X, Wu S, Shi T, Zhang P, et al. Thyroid stimulating hormone levels are associated with genetically predicted Nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2022;107(9):2522–2529. https://doi.org/10.1210/clinem/dgac393. (PubMed PMID: 35763044)
Zhang P, Ge Z, Wang H, Feng W, Sun X, Chu X, et al. Prolactin improves hepatic steatosis via CD36 pathway. J Hepatol. 2018;68(6):1247–1255. https://doi.org/10.1016/j.jhep.2018.01.035
Article CAS PubMed Google Scholar
Hutchison AL, Tavaglione F, Romeo S, Charlton M. Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): beyond insulin resistance. J Hepatol. 2023;79(6):1524–1541. https://doi.org/10.1016/j.jhep.2023.08.030. (Epub 20230918. PubMed PMID: 37730124.)
Article CAS PubMed Google Scholar
Ji X, Yin H, Gu T, Xu H, Fang D, Wang K, et al. Excessive free fatty acid sensing in pituitary lactotrophs elicits steatotic liver disease by decreasing prolactin levels. Cell Rep. 2024;43(7): 114465. https://doi.org/10.1016/j.celrep.2024.114465
Article CAS PubMed Google Scholar
Costa-Brito AR, Goncalves I, Santos CRA. The brain as a source and a target of prolactin in mammals. Neural Regen Res. 2022;17(8):1695–1702. https://doi.org/10.4103/1673-5374.332124.PubMedPMID:35017416;PubMedCentralPMCID:PMC8820687
Article CAS PubMed PubMed Central Google Scholar
Xiao F, Xia T, Lv Z, Zhang Q, Xiao Y, Yu J, et al. Central prolactin receptors (PRLRs) regulate hepatic insulin sensitivity in mice via signal transducer and activator of transcription 5 (STAT5) and the vagus nerve. Diabetologia. 2014;57(10):2136–2144. https://doi.org/10.1007/s00125-014-3336-3
Article CAS PubMed Google Scholar
Sestan M, Raposo B, Rendas M, Brea D, Pirzgalska R, Rasteiro A, et al. Neuronal-ILC2 interactions regulate pancreatic glucagon and glucose homeostasis. Science. 2025;387(6731): eadi3624. https://doi.org/10.1126/science.adi3624
Article CAS PubMed Google Scholar
Huang J, Tsang WY, Fang XN, Zhang Y, Luo J, Gong LQ, et al. FASN Inhibition decreases MHC-I degradation and synergizes with PD-L1 checkpoint blockade in hepatocellular Carcinoma. Cancer Res. 2024;84(6):855–871. https://doi.org/10.1158/0008-5472.CAN-23-0966. (PubMed PMID: 38486485)
Article CAS PubMed Google Scholar
Xie C, Lin Y, Qi C, Wang W, Yuan Y, Song D, et al. Neuro-endocrine-immune regulation of metabolic homeostasis. Cytokine Growth Factor Rev. 2025. https://doi.org/10.1016/j.cytogfr.2025.08.001. (Epub 20250805)
Cornejo MP, Hentges ST, Maliqueo M, Coirini H, Becu-Villalobos D, Elias CF. Neuroendocrine regulation of metabolism. J Neuroendocrinol. 2016. https://doi.org/10.1111/jne.12395. (PubMed PMID: 27114114; PubMed Central PMCID: PMC4956544)
Article PubMed PubMed Central Google Scholar
Liu T, Xu Y, Yi CX, Tong Q, Cai D. The hypothalamus for whole-body physiology: from metabolism to aging. Protein Cell. 2022;13(6):394–421. https://doi.org/10.1007/s13238-021-00834-x. (Epub 20210407)
Jais A, Bruning JC. Arcuate nucleus-dependent regulation of metabolism-pathways to Obesity and diabetes Mellitus. Endocr Rev. 2022;43(2):314–328. https://doi.org/10.1210/endrev/bnab025.PubMedPMID:34490882;PubMedCentralPMCID:PMC8905335
Article PubMed PubMed Central Google Scholar
Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature. 2001;411(6836):480–484. https://doi.org/10.1038/35078085. (PubMed PMID: 11373681)
Article CAS PubMed Google Scholar
Bicknell AB. The tissue-specific processing of pro-opiomelanocortin. J Neuroendocrinol. 2008;20(6):692–699. https://doi.org/10.1111/j.1365-2826.2008.01709.x. (PubMed PMID: 18601691)
Article CAS PubMed Google Scholar
Butler AA, Cone RD. Knockout studies defining different roles for melanocortin receptors in energy homeostasis. Ann N Y Acad Sci. 2003;994:240–245. https://doi.org/10.1111/j.1749-6632.2003.tb03186.x. (PubMed PMID: 12851322)
Article CAS PubMed Google Scholar
Quarta C, Claret M, Zeltser LM, Williams KW, Yeo GSH, Tschop MH, et al. POMC neuronal heterogeneity in energy balance and beyond: an integrated view. Nat Metab. 2021;3(3):299–308. https://doi.org/10.1038/s42255-021-00345-3. (Epub 20210225)
Article PubMed PubMed Central Google Scholar
Liu K, Yang L, Wang G, Liu J, Zhao X, Wang Y, et al. Metabolic stress drives sympathetic neuropathy within the liver. Cell Metab. 2021;33(3):666–75 e4. https://doi.org/10.1016/j.cmet.2021.01.012. (Epub 20210204)
Article CAS PubMed Google Scholar
Wang T, Tufenkjian A, Ajijola OA, Oka Y. Molecular and functional diversity of the autonomic nervous system. Nat Rev Neurosci. 2025. https://doi.org/10.1038/s41583-025-00941-2. (Epub 20250703)
Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908–922. https://doi.org/10.1038/s41591-018-0104-9. (Epub 20180702)
Article CAS PubMed PubMed Central Google Scholar
Ramos-Roman MA. Prolactin and lactation as modifiers of diabetes risk in gestational diabetes. Horm Metab Res. 2011;43(9):593–600. https://doi.org/10.1055/s-0031-1284353. (Epub 20110805)
Comments (0)